Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fda.gov

What's New: Drugs RSS Feed

Get the latest updates from What's New: Drugs RSS Feed directly as they happen.

Follow now 869 followers

Latest posts

Last updated about 10 hours ago

October 10, 2024: Meeting of the Cardiovascular and Renal Drugs Advisory Committee - 10/10/2024

about 10 hours ago

The Committee will discuss new drug application (NDA) 215244, for elamipretide hydrochloride...

Internet Pharmacy Warning Letters

about 17 hours ago

Rogue online pharmacies offer potentially dangerous prescription drugs to U.S. consumers. FDA...

Pharmaceutical Quality Resources

about 19 hours ago

FDA provides resources on pharmaceutical quality topics, including information on regulations, guidance...

News from Emerging Technology Program (ETP)

about 19 hours ago

CDER’s Office of Pharmaceutical Quality created the Emerging Technology Program to promote...

FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma

3 days ago

On June 18, 2025, the Food and Drug Administration approved tafasitamab-cxix (Monjuvi...

Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act

3 days ago

Section 505B(d)(1) requires FDA to send a PREA Non-Compliance letter to sponsors...

FDA adds warning about serious risk of heat-related complications with antinausea patch Transderm Scōp (scopolamine transdermal system)

3 days ago

The antinausea patch Transderm Scōp (scopolamine transdermal system) can increase body temperature...

Post-Warning Letter Meetings Under GDUFA

3 days ago

Post-Warning Letter Meetings Under GDUFA

Clinical Outcome Assessment (COA) Qualification Program: Frequently Asked Questions

4 days ago

CDER Clinical Outcome Assessments (COA) Qualification Program: Frequently Asked Questions (FAQs)

Qualified Clinical Outcome Assessments (COA)

4 days ago

The table below lists qualified Clinical Outcome Assessments (COA). The tables include...

FDA's ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neuroscience

4 days ago

FDA's Center for Drug Evaluation and Research (CDER) recently accepted a new...